ACELYRIN, INC. Appoints Biotechnology Veteran Gil M. Labrucherie as Chief Financial Officer

Labrucherie brings to ACELYRIN more than 25 years of public-company experience across finance, operations, legal and corporate development functions LOS ANGELES, July 12, 2022 /PRNewswire/ -- ACELYRIN, INC. today announced the appointment of Gil M. Labrucherie as Chief Financial Officer...

Click to view original post